Header Logo

Connection

Yahya Choonara to Surface Properties

This is a "connection" page, showing publications Yahya Choonara has written about Surface Properties.
Connection Strength

0,686
  1. A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases. J Pharm Sci. 2010 May; 99(5):2219-39.
    View in: PubMed
    Score: 0,087
  2. Construction and in vitro characterization of an optimized porosity-enabled amalgamated matrix for sustained transbuccal drug delivery. Int J Pharm. 2010 May 31; 391(1-2):79-89.
    View in: PubMed
    Score: 0,086
  3. Mechanistic evaluation of alginate-HEC gelisphere compacts for controlled intrastriatal nicotine release in Parkinson's disease. J Pharm Sci. 2009 Jun; 98(6):2059-72.
    View in: PubMed
    Score: 0,082
  4. Proteosaccharide combinations for tissue engineering applications. Carbohydr Polym. 2020 May 01; 235:115932.
    View in: PubMed
    Score: 0,043
  5. Antineoplastic nano-lipobubbles for passively targeted ovarian cancer therapy. Colloids Surf B Biointerfaces. 2019 May 01; 177:160-168.
    View in: PubMed
    Score: 0,040
  6. Ester-Based Hydrophilic Cyclodextrin Nanosponges for Topical Ocular Drug Delivery. Curr Pharm Des. 2016; 22(46):6988-6997.
    View in: PubMed
    Score: 0,032
  7. Parameters and characteristics governing cellular internalization and trans-barrier trafficking of nanostructures. Int J Nanomedicine. 2015; 10:2191-206.
    View in: PubMed
    Score: 0,031
  8. Design of chitospheres loaded with pristine polymer particles for extended drug delivery via polyelectrolyte complexation and particulate leaching. Int J Pharm. 2015 Feb 01; 479(1):189-206.
    View in: PubMed
    Score: 0,030
  9. Ligand-functionalized nanoliposomes for targeted delivery of galantamine. Int J Pharm. 2013 May 01; 448(1):267-81.
    View in: PubMed
    Score: 0,027
  10. Design and pharmaceutical evaluation of a nano-enabled crosslinked multipolymeric scaffold for prolonged intracranial release of Zidovudine. J Pharm Pharm Sci. 2013; 16(3):470-85.
    View in: PubMed
    Score: 0,026
  11. A novel stimuli-synchronized alloy-treated matrix for space-defined gastrointestinal delivery of mesalamine in the Large White pig model. J Control Release. 2013 Mar 28; 166(3):234-45.
    View in: PubMed
    Score: 0,026
  12. A novel pH-dependant and double crosslinked polymethacrylate-based polysphere matrix for enteric delivery of isoniazid. Pharm Dev Technol. 2013 Sep-Oct; 18(5):1066-77.
    View in: PubMed
    Score: 0,025
  13. The application of a crosslinked pectin-based wafer matrix for gradual buccal drug delivery. J Biomed Mater Res B Appl Biomater. 2012 May; 100(4):1029-43.
    View in: PubMed
    Score: 0,025
  14. A composite polyelectrolytic matrix for controlled oral drug delivery. AAPS PharmSciTech. 2011 Mar; 12(1):227-38.
    View in: PubMed
    Score: 0,023
  15. Investigating the effect of polymeric approaches on circulation time and physical properties of nanobubbles. Pharm Res. 2011 Mar; 28(3):494-504.
    View in: PubMed
    Score: 0,023
  16. Investigation of the physicochemical and physicomechanical properties of a novel intravaginal bioadhesive polymeric device in the pig model. AAPS PharmSciTech. 2010 Jun; 11(2):793-808.
    View in: PubMed
    Score: 0,022
  17. Design, biometric simulation and optimization of a nano-enabled scaffold device for enhanced delivery of dopamine to the brain. Int J Pharm. 2009 Dec 01; 382(1-2):277-90.
    View in: PubMed
    Score: 0,021
  18. Computational molecular modeling and structural rationalization for the design of a drug-loaded PLLA/PVA biopolymeric membrane. Biomed Mater. 2009 Feb; 4(1):015014.
    View in: PubMed
    Score: 0,020
  19. Elucidation of the physicomechanical and ab initio quantum energy transitions of a crosslinked PLGA scaffold. Biomaterials. 2007 Sep; 28(25):3714-23.
    View in: PubMed
    Score: 0,018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.